|
π
|
Mesenchymal differentiation mediated by NF-ΞΊB promotes radiation resistance in glioblastoma.
33 auth.
K. Bhat,
V. Balasubramaniyan,
B. Vaillant,
R. Ezhilarasan,
K. Hummelink,
Faith Hollingsworth,
K. Wani,
L. Heathcock,
Johanna D. James,
Lindsey D. Goodman,
S. Conroy,
L. Long,
Nina Lelic,
Suzhen Wang,
J. Gumin,
...
D. Raj,
Y. Kodama,
A. Raghunathan,
A. Olar,
Kaushal Joshi,
C. Pelloski,
A. Heimberger,
S. H. Kim,
D. Cahill,
G. Rao,
W. D. Den Dunnen,
H. Boddeke,
H. Phillips,
I. Nakano,
F. Lang,
H. Colman,
E. Sulman,
K. Aldape
|
9 |
2013 |
9
π
|
|
π
|
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion.
29 auth.
K. Tateishi,
H. Wakimoto,
A. Iafrate,
Shota Tanaka,
F. Loebel,
Nina Lelic,
D. Wiederschain,
Olivier Bedel,
G. Deng,
Bailin Zhang,
Timothy He,
Xu Shi,
R. Gerszten,
Yiyun Zhang,
J. Yeh,
...
W. Curry,
Dan Zhao,
Sudhandra Sundaram,
F. Nigim,
Mara V. A. Koerner,
Quan H Ho,
D. Fisher,
E. Roider,
L. KemΓ©ny,
Yardena Samuels,
K. Flaherty,
T. Batchelor,
A. Chi,
D. Cahill
|
8 |
2015 |
8
π
|
|
π
|
Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas
19 auth.
H. Wakimoto,
Shota Tanaka,
W. Curry,
F. Loebel,
Dan Zhao,
K. Tateishi,
Juxiang Chen,
Lindsay K. Klofas,
Nina Lelic,
James C. Kim,
...
D. Dias-Santagata,
L. Ellisen,
D. Borger,
S. Fendt,
M. V. Vander Heiden,
T. Batchelor,
A. Iafrate,
D. Cahill,
A. Chi
|
7 |
2014 |
7
π
|
|
π
|
Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma
12 auth.
K. Tateishi,
A. Iafrate,
Quan H Ho,
W. Curry,
T. Batchelor,
K. Flaherty,
...
M. Onozato,
Nina Lelic,
Sudhandra Sundaram,
D. Cahill,
A. Chi,
H. Wakimoto
|
6 |
2016 |
6
π
|
|
π
|
Rapid Intraoperative Molecular Characterization of Glioma.
30 auth.
G. Shankar,
J. Francis,
M. Rinne,
S. Ramkissoon,
F. Huang,
A. Venteicher,
E. AkamaβGarren,
Y. J. Kang,
Nina Lelic,
James C. Kim,
Loreal E Brown,
Sarah K Charbonneau,
A. Golby,
Chandra Sekhar Pedamallu,
M. Hoang,
...
R. Sullivan,
A. Cherniack,
L. Garraway,
A. Stemmer-Rachamimov,
D. Reardon,
P. Wen,
P. Brastianos,
W. Curry,
F. Barker,
W. Hahn,
B. Nahed,
K. Ligon,
D. Louis,
D. Cahill,
M. Meyerson
|
6 |
2015 |
6
π
|
|
π
|
The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1-Mutant Cancers and Potentiates NAD+ Depletion-Mediated Cytotoxicity.
15 auth.
K. Tateishi,
K. Tateishi,
Fumi Higuchi,
Julie J. Miller,
Mara V. A. Koerner,
Nina Lelic,
G. Shankar,
Shota Tanaka,
D. Fisher,
T. Batchelor,
...
A. Iafrate,
H. Wakimoto,
Andrew S. Chi,
Andrew S. Chi,
D. Cahill
|
6 |
2017 |
6
π
|
|
π
|
Sporadic hemangioblastomas are characterized by cryptic VHL inactivation
30 auth.
G. Shankar,
A. Taylor-Weiner,
Nina Lelic,
Robert Jones,
James C. Kim,
J. Francis,
M. Abedalthagafi,
L. Borges,
J. Coumans,
W. Curry,
B. Nahed,
John H. Shin,
S. Paek,
Sung-Hye Park,
C. Stewart,
...
M. Lawrence,
K. Cibulskis,
A. Thorner,
P. Van Hummelen,
A. Stemmer-Rachamimov,
T. Batchelor,
S. Carter,
M. Hoang,
S. Santagata,
D. Louis,
F. Barker,
M. Meyerson,
G. Getz,
P. Brastianos,
D. Cahill
|
6 |
2014 |
6
π
|
|
π
|
BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology
20 auth.
G. Shankar,
Nina Lelic,
C. Gill,
A. Thorner,
P. Van Hummelen,
J. Wisoff,
J. Loeffler,
P. Brastianos,
John H. Shin,
L. Borges,
...
W. Butler,
D. Zagzag,
R. Brody,
A. Duhaime,
Michael D. Taylor,
C. Hawkins,
D. Louis,
D. Cahill,
W. Curry,
M. Meyerson
|
5 |
2015 |
5
π
|
|
π
|
PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors
34 auth.
K. Tateishi,
Taishi Nakamura,
T. Juratli,
E. Williams,
Y. Matsushita,
S. Miyake,
M. Nishi,
Julie J. Miller,
Shilpa S. Tummala,
Alexandria L. Fink,
Nina Lelic,
Mara V. A. Koerner,
Yohei Miyake,
Jo Sasame,
K. Fujimoto,
...
Takahiro Tanaka,
R. Minamimoto,
S. Matsunaga,
S. Mukaihara,
T. Shuto,
H. Taguchi,
N. Udaka,
Hidetoshi Murata,
A. Ryo,
S. Yamanaka,
W. Curry,
D. Dias-Santagata,
Tetsuya Yamamoto,
K. Ichimura,
T. Batchelor,
A. Chi,
A. Iafrate,
H. Wakimoto,
D. Cahill
|
4 |
2019 |
4
π
|
|
π
|
A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.
12 auth.
F. Nigim,
S. Esaki,
Michael Hood,
Nina Lelic,
M. James,
V. Ramesh,
...
A. Stemmer-Rachamimov,
D. Cahill,
P. Brastianos,
S. Rabkin,
R. Martuza,
H. Wakimoto
|
4 |
2016 |
4
π
|
